170817 ⎘
Detection or diagnosis of diseases; Pulmonary diseases Chronic or obstructive airway disorders, e.g. asthma COPD
Pulse Stable Tracer Methods for Detection of Short-Chain Fatty Acids
#2METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#3BIOMARKERS FOR DIAGNOSING EQUINE ASTHMA
#4ANTIBODIES THAT BIND TO IGE-DEPENDENT HISTAMINE-RELEASING FACTOR AND USES THEREOF
#5METHODS RELATING TO RESPIRATORY HEALTH THERAPEUTICS
#6METHODS FOR IMPROVING OUTCOMES FOR HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS AT RISK FOR BRONCHIOLITIS OBLITERANS SYNDROME
#7FLUTICASONE FUROATE IN THE TREATMENT OF COPD
#8SENSING DEVICE FOR PREDICTING THE RISK OF AN COPD AND/OR ASTHMA ATTACK, MEASUREMENT ARRANGEMENT AND METHOD FOR THE MAINTENANCE OF THE SENSING DEVICE
#9MONITORING INFLAMMATION STATUS
#10BIOMARKER
#11Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#12COLLAGEN TYPE VII ALPHA 1 ASSAY
#13METHODS TO IDENTIFY AND TREAT SUBJECTS HAVING CORTICOSTEROID-RESISTANT INFLAMMATORY DISEASES
#14PROTEIN SIGNATURES FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#15Method for diagnosis of lung disease based on antibodies for microbial-derived vesicles
#16Apparatus for Detecting and Monitoring Exhaled Breath
#17SYSTEMS AND METHODS FOR MONITORING RESPIRATORY GASES
#18LOW SHEAR MICROFLUIDIC DEVICES AND METHODS OF USE AND MANUFACTURING THEREOF
#19METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#20NANOSENSORS FOR RAPID IDENTIFICATION OF LUNG CONDITIONS
#21TNF-ALPHA AND IL-1ALPHA POSITIVE COPD TREATMENT WITH ANTIBIOTICS
#22METHODS AND DESIGN OF LUNG HEALTH DIAGNOSTIC (LHDx) TECHNOLOGY FOR DIAGNOSIS AND PROGNOSIS-BASED INTERVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISORDER (COPD), EMPHYSEMA AND AGE-RELATED LUNG DISEASES
#23Elastin Assay
#24METHODS FOR TREATING EXACERBATIONS OF INFLAMMATORY RESPIRATORY DISEASES
#25METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#26METHODS OF DETECTING LIPOARABINOMANNAN AND DIAGNOSING NONTUBERCULOSIS MYCOBACTERIAL INFECTION
#27METHOD FOR ASSAYING LOWER RESPIRATORY TRACT INFECTION OR INFLAMMATION
#28Cyclooxygenase-2 Inhibition for the Treatment of SAA-high Asthma
#29DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#30Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#31Detection of glucuronidated and 3-bromotyrosine
#32Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
#33ISOLATION OF CELLS OF EPITHELIAL ORIGIN CIRCULATING IN PERIPHERAL BLOOD
#34Methods of treating chronic disorders with complement inhibitors
#35Protein signatures for distinguishing between bacterial and viral infections
#36METHODS FOR TARGETED ASSESSMENT AND TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ACUTE EVENTS AND MORTALITY ASSOCIATED THEREWITH
#37DETECTION AND TREATMENT OF IL-17 AND IL-13 RELATED CONDITIONS
#38Methods of detecting and treating airway inflammatory diseases
#39Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection
#40Detection of glutathionylated proteins
#41COLLAGEN TYPE VII ALPHA 1 ASSAY
#42Methods and compositions for treating asthma and allergic diseases
#43METHOD FOR TREATING ASTHMA OR ALLERGIC DISEASE
#44IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#45FLUTICASONE FUROATE IN THE TREATMENT OF COPD
#46Low cost test strip and method to measure analyte
#47SYSTEM AND METHOD FOR DETERMINING LUNG HEALTH
#48Method for detecting and monitoring exhaled breath
#49Low shear microfluidic devices and methods of use and manufacturing thereof
#50METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#51A DEVICE AND METHOD TO DETERMINE THE MEAN/AVERAGE CONTROL OF ASTHMA/COPD OVER TIME AND COMPLIANCE TO TREATMENT
#52Diagnosis of asthma versus chronic obstructive pulmonary disease (COPD) using urine metabolomic analysis
#53Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung Cancers
#54METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#55Predicting the onset of a physiological condition of a subject using a digital biophysical model
#56Methods of treating chronic disorders with complement inhibitors
#57COMPOSITIONS AND METHODS FOR DETECTION OF DISEASES RELATED TO EXPOSURE TO INHALED CARCINOGENS
#58METHODS FOR DIAGNOSING INFLAMMATORY PHENOTYPES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#59Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract
#60Anti-human migration stimulating factor (MSF) and uses thereof
#61ISOLATION OF CELLS OF EPITHELIAL ORIGIN CIRCULATING IN PERIPHERAL BLOOD
#62Devices and methods related to airway inflammation
#63Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#64NASAL BIOMARKERS OF ASTHMA
#65Methods for diagnosing or predicting chronic bronchitis
#66Image selection suggestions
#67DIAGNOSTIC METHODS FOR INFLAMMATORY DISORDERS
#68BIOMARKER COMBINATIONS FOR MONITORING CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND/OR ASSOCIATED MECHANISMS
#69Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
#70ALX receptor ligands define a biochemical endotype for inflammation-based diseases
#71Methods and systems of detecting plasma protein biomarkers for diagnosing acute exacerbation of COPD
#72IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#73INTEGRATED DEVICE FOR LUNG HEALTH ASSESSMENT
#74Lytic peptide biosensor and methods of making and using the same
#75LYTIC PEPTIDE BIOSENSOR AND METHODS OF MAKING AND USING THE SAME
#76Detection of glucuronidated and 3-bromotyrosine
#77COLLAGEN TYPE VII ALPHA 1 ASSAY
#78METHODS OF TREATING CHRONIC DISORDERS WITH COMPLEMENT INHIBITORS
#79IDENTIFICATION OF NOVEL LOCI IN ASTHMA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF ASTHMA
#80Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#81Method of treating asthma using an IL-13 antibody
#82METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
#83Protein signatures for distinguishing between bacterial and viral infections
#84METHODS OF DETECTING AND TREATING AIRWAY INFLAMMATORY DISEASES
#85Methods of Treating Subjects having Severe and/or Persistent Asthma
#86Methods for decreasing chord length
#87Methods to identify and treat subjects having corticosteroid-resistant inflammatory diseases
#88METHODS OF DETECTING AND QUANTIFYING IL-13 AND USES IN DIAGNOSING AND TREATING TH2-ASSOCIATED DISEASES
#89ANTIBODIES, COMPOUNDS AND SCREENS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA
#90Quantification of inflammatory molecules in exhaled breath condensate using differential pulse voltammetry on reduced graphene oxide sensor
#91Methods of selectively treating asthma using IL-17 antagonists
#92USE OF CELL-FREE NUCLEOSOMES AS BIOMARKERS IN SPUTUM SAMPLES
#93Methods for detection of emphysema
#94Methods of treating and/or preventing chronic obstructive pulmonary disease
#95Biochemical Markers for Pulmonary and Other Diseases
#96Method for assaying lower respiratory tract infection or inflammation
#97Biomarkers in Peripheral Blood Mononuclear Cells for Diagnosing or Detecting Lung Cancers
#98Apparatus, Compositions, and Methods for Assessment of Chronic Obstructive Pulmonary Disease Progression Among Rapid and Slow Decline Conditions
#99DETECTION OF GLUTATHIONYLATED PROTEINS
#100Methods of using antibodies to determine periostin levels in a sample
#101NOVEL ASSAY TO DETECT HUMAN PERIOSTIN
#102METHODS OF VALIDATING CANDIDATE COMPOUNDS FOR USE IN TREATING COPD AND OTHER DISEASES
#103Diagnosis of asthma versus chronic obstructive pulmonary disease (COPD) using urine metabolomic analysis
#104Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract
#105METHOD OF DIGITIZING NUTRITIONAL STATUS, MUSCLE TURNOVER, AND RISK ASSESSMENT
#106METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES
#107Risk Factors of Cigarette Smoke-Induced Spriometric Phenotypes
#108Methods for treating or preventing asthma by administering an IL-4R antagonist
#109COPD Biomarker Signatures
#110COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA
#111ANTI-HIMF ANTIBODIES TO TREAT LUNG DISEASES
#112IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#113Fluticasone furoate in the treatment of COPD
#114Human exhaled aerosol droplet biomarker system and method
#115Methods for treating medical conditions by anti-type 2 therapy
#116P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH B-1 INTEGRIN ACTIVATION
#117Therapeutic agent for emphysema and COPD
#118Low cost test strip and method to measure analyte
#119Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
#120METHODS FOR ASSESSING RESPONSIVENESS TO ASTHMA TREATMENT BASED ON VNN-1 EXPRESSION AND PROMOTER METHYLATION
#121Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
#122Treating infection
#123Methods for detection of respiratory diseases
#124Porous semiconductor metal oxide complex nanofibers including nanoparticle catalyst functionalized by nano-catalyst included within metal-organic framework, gas sensor and member using the same, and method of manufacturing the same
#125SUBSTITUTED AMINO TRIAZOLES USEFUL AS ACIDIC MAMMALIAN CHITINASE INHIBITORS
#126DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN ASTHMATIC LUNG
#127METHODS OF DIAGNOSING AND TREATING ASTHMA
#128Biochemical markers for pulmonary and other diseases
#129Method for diagnosing lung diseases
#130Low shear microfluidic devices and methods of use and manufacturing thereof
#131METHODS FOR TREATING ALLERGIC AIRWAY INFLAMMATION
#132Monoclonal antibodies which bind human periostin
#133LIVER X RECEPTOR AGONISTS IN THE TREATMENT OF EMPHYSEMA
#134Method for detecting nucleosomes containing histone variants
#135Methods of Treating Subjects having Severe and/or Persistent Asthma
#136METHODS FOR TREATING LUNG DISEASE
#137METHOD, MATERIALS AND APPARATUS FOR INVESTIGATING ASTHMA USING DUST MITE ALLERGEN
#138Treatment of chronic obstructive pulmonary disease (COPD)
#139Devices and methods related to airway inflammation
#140Diagnosis and treatment of chronic obstructive pulmonary disease (COPD) based on elevated levels of extracellular H3 protein
#141DIAGNOSIS AND RISK STRATIFICATION USING NT-proET-1
#142Prognosis of chronic obstructive pulmonary disease (COPD) and treament for COPD
#143FEN1 AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#144METHODS OF DIAGNOSING AND TREATING ASTHMA
#145METHODS FOR ANALYZING ELASTIC FIBER INJURY MARKERS AND DIAGNOSIS OF DISEASES ASSOCIATED WITH ELASTIC FIBER INJURY
#146Method for diagnosis and prognosis of chronic obstructive pulmonary disease (COPD)
#147Galactoside inhibitor of galectins
#148Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof
#149Methods to identify and treat subjects having corticosteroid-resistant asthma
#150Cell culture models for validating candidate compounds for use in treating COPD and other diseases
#151METHOD FOR OBTAINING DATA THAT ARE USEFUL FOR THE DIAGNOSIS, PROGNOSIS AND CLASSIFICATION OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND/OR LUNG CANCER
#152Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#153Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis
#154Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers
#155Semaphorin 3A for treatment and assessment of severity of Asthma
#156Genetic Polymorphisms Associated With Advanced Lung Diseases
#157METHOD AND SYSTEM FOR IDENTIFYING LEAKY LUNG EPITHELIAL BARRIER
#158METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES
#159Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
#160IL-19 AS A BIOMARKER OF TSLP TREATMENT
#161SYSTEM, AN APPARATUS AND A COMPUTER PROGRAM PRODUCT FOR OBTAINING AN INFORMATION RELATED TO EOSINOPHILIC AIRWAY INFLAMMATION
#162PREDICTION OF OUTCOME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#163ARMET AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
#164Pro-inflammatory mediators in diagnosis and treatment of chronic obstructive pulmonary disease
#165Systemic genotoxicity as blood marker for allergic inflammation
#166Methods of treating chronic disorders with complement inhibitors
#167BIOMARKER FOR CHRONIC INFLAMMATORY LUNG DISEASES
#168Diagnosis and treatment of chronic obstructive pulmonary disease (COPD)
#169Granzyme A and granzyme B diagnostics
#170Therapeutic agent for emphysema and COPD
#171Combination pharmaceuticals and methods thereof using proteinacious channels as treatments for medical conditions
#172Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof
#173Galactoside inhibitor of galectins
#174Peptide for protection of allergic respiratory disorders
#175Human exhaled aerosol droplet biomarker system and method
#176Diagnosis and treatments relating to TH2 inhibition
#177Diagnosis and treatments relating to TH2 inhibition
#178ASC as a marker for chronic obstructive pulmonary disease (COPD)
#179Methods of validating candidate compounds for use in treating COPD and other diseases
#180Method for the diagnosis and/or prognosis of granulocyte-related inflammatory states
#181Biomarkers of lung function
#182Metabolomics-based biomarkers for lung function
#183Methods of treating obstructive lung diseases using bitter tastants
#184Asthma diagnosis using the neuropilin-1 gene, and method for screening for a therapeutic agent for asthma
#185Small molecule inhibitors of protein kinases
#186MATERIALS AND METHODS FOR DIAGNOSIS OF ASTHMA
#187METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS
#188DIAGNOSIS AND RISK STRATIFICATION OF INFECTIONS AND CHRONIC DISEASES OF THE RESPIRATORY TRACT AND LUNGS BY MEANS OF PROVASOPRESSIN, PARTICULARLY COPEPTIN OR NEUROPHYSIN II
#189BIOMARKERS FOR PROGNOSES OF PULMONARY DISEASES
#190RAPID SACCHARIDE BIOMARKER ASSAY
#191Method for diagnosing and treating emphysema
#192Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof
#193GENETIC POLYMORPHISMS ASSOCIATED WITH ADVANCED LUNG DISEASES
#194DIAGNOSIS AND TREATMENTS RELATING TO TH2 INHIBITION
#195METHOD FOR TREATING LUNG DISEASE
#196Compositions, antibodies, asthma diagnosis methods, and methods for preparing antibodies
#197Methods for treating and diagnosing fibrotic and fibroproliferative diseases
#198METHODS AND COMPOSITIONS RELATED TO THE REGULATION OF GOBLET CELL DIFFERENTIATION, MUCUS PRODUCTION AND MUCUS SECRETION
#199Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
#200HK1-BINDING PROTEINS
#201Methods of detecting and treating pulmonary disease and markers thereof
#202Naphthalene-based inhibitors of anti-apoptotic proteins
#203Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#204Variant of mite allergen and uses thereof
#205Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis
#206Compositions, methods and animal models for screening therapeutics for TH2-type disease
#207Biomarkers in peripheral blood mononuclear cells for diagnosing or detecting lung cancers
#208SELECTIVE DIFFERENTIATION, IDENTIFICATION, AMD MODULATION OF HUMAN TH17 CELLS
#209Chitin-induced immune response based method for diagnosing allergic asthma in patients
#210Method for the preventing and/or treating IL-1 beta lung pathology in mammals by administering a uric acid reducing compound
#211METHOD OF DIAGNOSING A RESPIRATORY DISEASE
#212MMP activation peptide detection in biological samples
#213P-SELECTIN ASSOCIATED WITH EOSINOPHILS AS A MARKER FOR ASTHMA AND CORRELATING WITH B-1 INTEGRIN ACTIVATION
#214NOVEL 15571, 2465, 14266, 2882, 52871, 8203 AND 16852 MOLECULES AND USES THEREFOR
#215Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract
#216SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES
#217COPD BIOMARKER SIGNATURES
#218METHOD FOR DIAGNOSING AND TREATING EMPHYSEMA
#219METHOD OF DIAGNOSIS
#220MOLECULAR SIGNATURE FOR FIBROSIS AND ATROPHY
#221COPD diagnosis
#222Cellular COPD Diagnosis
#223CHEMICAL MODULATION OF ELECTRONIC AND MAGNETIC PROPERTIES OF GRAPHENE
#224METHOD FOR TESTING A SUBJECT THOUGHT TO HAVE OR TO BE PREDISPOSED TO ASTHMA
#225Diagnosis and risk stratification using NT-proET-1
#226Granzyme A and granzyme B diagnostics
#227METHODS AND COMPOSITIONS FOR ASSESSMENT OF PULMONARY FUNCTION AND DISORDERS
#228Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
#229Naphthalene-based inhibitors of anti-apoptotic proteins
#230Materials and Methods for Diagnosis of Asthma
#231Peptide Fingerprint from the Degradation of Elastin by HNE
#232Diagnosis of conditions associated with decreased arginine bioavailability
#233Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease
#234Compositions and Methods for Detecting and Quantifying Toxic Substances in Disease States
#235METHOD OF DIAGNOSING AND TREATING ASTHMA
#236Surfactant Protein D is a Biomarker for Steroid Responsiveness in Asthma and Chronic Obstructive Pulmonary Disease
#237COPD DETERMINATION
#238Toll-LIke Receptor 4 Deficiency and Downstream Effectors Cause Pulmonary Emphysema
#239Methods for treating and diagnosing fibrotic and fibroproliferative diseases
#240Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II
#241Anti-HIMF antibodies to treat lung diseases
#242Method for Determining the Activity of a Protease in a Sample
#243Filaggrin
#244Gene Expression Profiles Associated with Asthma Exacerbation Attacks
#245Use of A33 antigens and JAM-IT
#246Method for measuring activity of a specific fraction of albumin
#247Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
#248Inhibitors of Reglll Proteins as Asthma Therapeutics
#249AGENTS FOR IMPROVING CHRONIC OBSTRUCTIVE PULMONARY DISEASES
#250EXPRESSION OF ORPHAN GPR64 IN INFLAMMATORY DISEASES
#251COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES
#252ASSESSMENT OF ASTHMA AND ALLERGEN-DEPENDENT GENE EXPRESSION
#253Methods and Compositions Relating to Vascular Endothelial Growth Factor and TH2 Mediated Inflammatory Diseases
#254METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES
#255Molecular phenotyping of severe asthma
#256P-Selectin associated with Eosinophils as a marker for asthma and correlating with B-1 integrin activation
#257Animal Model for Assessing Copd-Related Diseases
#258Use of A33 antigens and JAM-it
#259BETA 1 INTEGRIN ACTIVATION AS A MARKER FOR ASTHMA
#260Inflammation treatment, detection and monitoring via TREM-1
#261METHODS FOR DETERMINING THE STATUS OF COPD IN HUMANS
#262HK1-binding proteins
#263Dephosphorylation of HDAC7 By Myosin Phosphatase
#264Single nucleotide polymorphisms in protein-tyrosine phosphatase receptor-type delta for the diagnosis of susceptibility to asthma
#265Blockade of Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma by Insulin-Like Growth Factor Binding Protein-3 (Igfbp-3)
#266Composition for Prevention, Treatment, and Diagnosis of Chronic Inflammatory Airway Diseases
#267BIOMARKERS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#268COMPOSITIONS AND METHODS FOR DETECTING AND QUANTIFYING TOXIC SUBSTANCES IN DISEASE STATES
#269Apparatus, compositions, and methods for assessment of chronic obstructive pulmonary disease progression among rapid and slow decline conditions
#270Biological dataset profiling of asthma and atopy
#271Detection of glutathionylated proteins
#272Method, materials and apparatus for investigating asthma using dust mite allergen
#273Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
#274ASTHMA DIAGNOSIS AND THERAPY
#275METHOD FOR EVALUATING ASTHMA CONTROL
#276Polynucleotides encoding human SLAP-2 variant, hSLAP-2v3
#277Methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3
#278Therapeutic target and diagnostic marker for asthma and related conditions
#279Method of detecting the presence of asthma or allergies in a patient
#280Use of A33 antigens and JAM-IT
#281Inhibitors of gob-4 protein as asthma therapeutics
#282Single nucleotide polymorphisms in protein-tyrosine phosphatase receptor-type delta for the diagnosis of susceptibility to infection and asthma
#283Novel ubp8rp polypeptides and their use in the treatment of psoriasis
#284Rapid serum sugar biomarker assay of rheumatoid arthritis
#285Compositions and methods for IL-13 biomarkers
#286Computer systems and methods for inferring casuality from cellular constituent abundance data
#287Use of A33 antigens and jam-it
#288Antibodies that bind hK-1
#289Elastin peptide fingerprints and analysis methods for MMP12 related to COPD
#290Human monoclonal antibodies that bind to very late antigen-1 for the treatment of inflammation and other disorders
#291Methods and compositions for assessment of pulmonary function and disorders
#292Computer systems and methods for inferring causality from cellullar constituent abundance data
#293Use of A33 antigens and JAM-it
#294Systemic markers for asthma and analogous diseases
#295Test kit
#296Eotaxin: eosinophil chemotactic cytokine
#297Diagnosis of conditions associated with decreased arginine bioavailability
#298Method for monitoring the effectiveness of teracycline in the treatment of asthma
#299Plasma C5A levels as an indicator of asthma severity
#300Genetic predictor of efficacy of anti-asthmatic agents for improving pulmonary function